Page last updated: 2024-08-24

meglumine antimoniate and Dizzyness

meglumine antimoniate has been researched along with Dizzyness in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Araujo-Melo, MH; Araújo-Silva, M; Carmo, CN; Conceição-Silva, F; Meneses, AM; Moreira, JS; Oliveira, RV; Pimentel, MI; Salgueiro, MM; Schubach, AO; Valete-Rosalino, CM	1

Other Studies

1 other study(ies) available for meglumine antimoniate and Dizzyness

Article	Year
Risk factors associated with dizziness during treatment of mucosal leishmaniasis with meglumine antimoniate: 16-year retrospective study of cases from Rio de Janeiro, Brazil. The Journal of laryngology and otology, 2010, Volume: 124, Issue:10 Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Dizziness; Dose-Response Relationship, Drug; Female; Humans; Leishmaniasis, Mucocutaneous; Lipase; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Odds Ratio; Organometallic Compounds; Retrospective Studies; Risk Factors; Sex Distribution; Young Adult	2010

Article

Year

Risk factors associated with dizziness during treatment of mucosal leishmaniasis with meglumine antimoniate: 16-year retrospective study of cases from Rio de Janeiro, Brazil.

The Journal of laryngology and otology, 2010, Volume: 124, Issue:10

Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Dizziness; Dose-Response Relationship, Drug; Female; Humans; Leishmaniasis, Mucocutaneous; Lipase; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Odds Ratio; Organometallic Compounds; Retrospective Studies; Risk Factors; Sex Distribution; Young Adult

2010